Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/55247
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Rosón, Beatriz |
dc.contributor.author | Carratalà, Jordi |
dc.contributor.author | Tubau, Fe |
dc.contributor.author | Dorca i Sargatal, Jordi |
dc.contributor.author | Liñares Louzao, Josefina |
dc.contributor.author | Pallarés Giner, Roman |
dc.contributor.author | Manresa, Federico |
dc.contributor.author | Gudiol i Munté, Francesc |
dc.date | 2014-06-26T10:31:35Z |
dc.date | 2014-06-26T10:31:35Z |
dc.date | 2001-03 |
dc.date | 2014-06-26T10:31:35Z |
dc.identifier.citation | 1076-6294 |
dc.identifier.citation | 536038 |
dc.identifier.uri | http://hdl.handle.net/2445/55247 |
dc.format | 12 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Mary Ann Liebert, Inc. |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1089/107662901750152864 |
dc.relation | Microbial Drug Resistance, 2001, vol. 7, num. 1, p. 85-96 |
dc.relation | http://dx.doi.org/10.1089/107662901750152864 |
dc.rights | (c) Mary Ann Liebert, Inc., 2001 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Estreptococs |
dc.subject | Resistència als medicaments |
dc.subject | Amoxicil·lina |
dc.subject | Medicaments antibacterians |
dc.subject | Penicil·lina |
dc.subject | Pneumònia |
dc.subject | Pneumococs |
dc.subject | Streptococcus |
dc.subject | Drug resistance |
dc.subject | Amoxicillin |
dc.subject | Antibacterial agents |
dc.subject | Penicillin |
dc.subject | Pneumonia |
dc.subject | Streptococcus pneumonia |
dc.title | Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |